Deaths From Heart Disease, Stroke, and Hypertensive Disease United States, 2001-2010. Morbidity and Mortality Weekly Report. 2013;62(35):721-7.
14. Martin SS, Feldman DI, Blumenthal RS, et al. Abstract 11: mActive: a blinded, randomized health trial supporting digital tracking and smart texting for promotion of physical activity. Circulation. 2015;131:A11.
15. Benavente OR, Coffey CS, Conwit R, et al; SPS3 Study Group. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet2013;382(9891):507-15.
16. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Monique Verschuren WM, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur J Prev Cardiol 2012;19:585-667.
17. Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 2011;124:2458-73.
18. Yusuf S, Islam S, Chow CK, Rangarajan S, Dagenais G, Diaz R, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet 2011;378:1231-43.
19. Neal Axon R, Yumin Z, Egan BM: US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA 2010, 303:2043–50
20. Tocci G, Rosei EA, Ambrosioni E, Borghi C, Ferri C, Ferrucci A, et al.: Blood pressure control in Italy: analysis of clinical data from 2005–2011 surveys on hypertension. J Hypertens 2012, 30:1065–1074.
21. McAlister FA, Kathryn W, Michel J, Frans HH L, George F, Marianne G, et al.: Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ 2011, 183:1007–13.
22. Kronborg CN, Hallas J, Jacobsen IA: Prevalence, awareness, and control of arterial hypertension in Denmark. J Am Soc Hypertens 2009, 3:19–24.e2.
23. Neutel JM: Long-term blood pressure control: what can we do? Postgrad Med 2011, 123:88–93.
24. Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T: Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev 2010., 17(3) CD005182
25. Hodgkinson J, Mant J, Martin U, Guo B, Hobbs FDR, Deeks JJ, et al.: Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review. BMJ 2011, 342:d3621.
26. Stewart S, Carrington MJ, Swemmer CH, Anderson C, Kurstjens AC, Amerena J, et al.: Effect of intensive structured care on individual blood pressure targets in primary care: multicentre randomised controlled trial. BMJ 2012, 345:e715–6.
27. Serumaga B, Ross-Degnan D, Avery AJ, Elliott RA, Majumdar SR, Zhang F, Soumerai SB: Effect of pay for performance on the management and outcomes of hypertension in the United Kingdom: interrupted time series study. BMJ 2011, 25:342.
28. Piper MA, Evans CV, Burda BU, Margolis KL, O’Connor E, Smith N, et al. Screening for High Blood Pressure in Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force. Evidence Synthesis No. 121. AHRQ Publication No. 13-05194-EF-1. Rockville, MD: Sponsored by Agency for Healthcare Research and Quality; 2014.
29. De Alleaume, L. Parnes, B. Zittleman, L. Sutter, C. Chavez, R. Bernstein, J. et al. Success in the Achieving CARdiovascular Excellence in Colorado (A CARE) Home Blood Pressure Monitoring Program. J Am Board Fam Med. 2015;28(5):548-55.
30. National Institutes of Health. Landmark NIH study shows intensive blood pressure management may save lives [press release]. September 11, 2015. http://www.nhlbi.nih.gov/news/press-releases/2015/landmark-nih-study-shows-intensive-blood-pressure-management-may-save-lives Accedido September 16, 2015.
31. Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012. NCHS Data Brief. 2013;(133):1-8.
32. Viera AJ, Lingley K, Hinderliter AL. Tolerability of the Oscar 2 ambulatory blood pressure monitor among research participants: a cross-sectional repeated measures study. BMC Med Res Methodol. 2011;11:59.
33. Nasothimiou EG, Karpettas N, Dafni MG, Stergiou GS. Patients’ preference for ambulatory versus home blood pressure monitoring. J Hum Hypertens. 2014;28(4):224-9.
34. Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012. NCHS Data Brief. 2013;(133):1-8.
35. Ferrer Santos V, Domínguez Hernández M, Méndez Rosabal A. La hipertensión arterial como causa de mortalidad. Rev Cub Med Mil [Internet]. 2011 Jun [citado 2015 Mayo 01] ; 40(2): 168-173. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S0138-65572011000200008&lng=es.
36. Martin SS, Feldman DI, Blumenthal RS, et al. Abstract 11: Active: a blinded, randomized health trial supporting digital tracking and smart texting for promotion of physical activity. Circulation. 2015;131:A11.
37. He FJ, Li J, Macgregor GA. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ. 2013;346:f1325.
38. US Department of Agriculture and US Department of Health and Human Services. [Internet] Washington, Dietary Guidelines for Americans, 2010. 7th Edition. Washington, DC: US Government Printing Office; December 2010. [Citado mayo 2015] Disponible en http://www.cnpp.usda.gov/sites/default/files/dietary_guidelines_for_americans/PolicyDoc.pdf
39. Nordfors L, Luttropp K, Carrero JJ, Witasp A, Stenvinkel P, Lindholm B, et al. Genetic studies in chronic kidney disease: basic concepts. J Nephrol. Mar-Apr 2012;25(2):141-9.
40. Su SL, Lu KC, Lin YF, Hsu YJ, Lee PY, Yang HY, et al. Gene polymorphisms of angiotensin-converting enzyme and angiotensin II type 1 receptor among chronic kidney disease patients in a Chinese population. J Renin Angiotensin Aldosterone Syst. Mar 2012;13(1):148-54
41. Avery, C. L., Holliday, K. M., Chakladar, S., Lin, D. Y., Moncrieft, A. E., Ostfeld, R. J. Zeng, D. Early Loss of Normal Body Weight in Multiethnic US Populations: The Hispanic Community Health Study/Study of Latinos (HCHS/SOL), Strong Heart Family Study (SHFS), and the National Health and Nutrition Examination Survey (NHANES). Circulation 2015; 131(Suppl 1): A33-A33.